Home › NDC Lookup › RxCUI directory › RxCUI 2166927

10 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Inhalation Spray — RxCUI 2166927

RxNorm drug concept · Semantic clinical drug
RxCUI 2166927 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2166927
Official name10 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Inhalation Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asolodaterol 2.5 MCG / tiotropium 2.5 MCG per ACTUAT Metered Dose Inhalation Spray, 10 ACTUAT; olodaterol 2.5 MCG (as olodaterol HCl 2.736 MCG) / tiotropium 2.5 MCG (as tiotropium bromide 3.124 MCG) per ACTUAT Metered Dose Inhalation Spray, 10 ACTUAT
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)135,065 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tiotropium Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Spiriva Respimat is a daily controller for COPD, including chronic bronchitis and emphysema, and it helps reduce flare-ups. It is also used for asthma in people 6 and older. It kee...
  • No. It is not a rescue inhaler and will not relieve sudden symptoms. Keep your fast-acting inhaler as your doctor directed and get help if breathing gets worse.
  • Can I use it when I suddenly can't breathe well?
  • Take two inhalations by mouth once a day, and never more than one dose in 24 hours. The inhaler must be primed before first use. Food does not matter. In asthma, full benefit can t...
📖 Read our full Tiotropium Oral Inhalation guide →

🕸️ Concept Web — How 10 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Inhalation Spray RxCUI 2166927

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Olodaterol 1546059
    • Tiotropium 69120
    • Olodaterol / tiotropium 1658460
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Stiolto 1651267
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Olodaterol / tiotropium Inhalation Spray 2284646
    • Olodaterol / tiotropium Inhalant Product 1658458
    • Olodaterol / tiotropium Inhalation Spray [Stiolto] 2284648
    • Stiolto Inhalant Product 1651270
    • Inhalation Spray 2284289
    • Inhalant Product 1151123
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Olodaterol 0.0025 MG/ACTUAT SCDC · 1546076
  • Tiotropium 0.0025 MG/ACTUAT SCDC · 1551894
  • Olodaterol / tiotropium Inhalation Spray SCDF · 2284646
  • Olodaterol / tiotropium Inhalant Product SCDG · 1658458

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2166927 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0155-28 1 CARTRIDGE in 1 CARTON (0597-0155-28) / 28 SPRAY, METERED... Stiolto Respimat Boehringer Ingelheim Pharmaceuticals, Inc. 2015-05-21
00597-0155-61 1 CARTRIDGE in 1 CARTON (0597-0155-61) / 60 SPRAY, METERED... Stiolto Respimat Boehringer Ingelheim Pharmaceuticals, Inc. 2015-05-21
00597-0155-70 1 CARTRIDGE in 1 CARTON (0597-0155-70) / 10 SPRAY, METERED... Stiolto Respimat Boehringer Ingelheim Pharmaceuticals, Inc. 2019-03-22
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$115.8140
Range $115.8140–$115.8140 · middle 50% $115.8140–$115.8140 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.